Showing results (1-10 of 93) with videos related to
Sort By:
Pageof 10
Expert Opinion on Therapeutic Patents|July 4, 2017
Between pharmaceutical patents and European patients: is a compromise still possible?Livio Garattini, Anna PadulaThe European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 3, 2020
Correction to: Defensive medicine in Europe: a 'full circle'?Livio Garattini, Anna PadulaJournal of the Royal Society of Medicine|January 14, 2017
Cholesterol-lowering drugs: science and marketingLivio Garattini, Anna PadulaJournal of Medical Economics|July 8, 2011
Management of vaccinations in Italy: a national survey after healthcare regionalizationLivio Garattini, Anna Padula, Gianluigi CasadeiInternal and Emergency Medicine|March 4, 2020
Conflicts of interest in medicine: a never-ending storyLivio Garattini, Anna Padula, Pier Mannuccio MannucciInternal and Emergency Medicine|September 13, 2020
Community and hospital pharmacists in Europe: encroaching on medicine?Livio Garattini, Anna Padula, Pier Mannuccio MannucciInternal and Emergency Medicine|February 12, 2011
Economic evaluation of human papilloma virus vaccination in the European Union: a critical reviewDaniela Koleva, Paola De Compadri, Anna Padula, et al.Health Policy (Amsterdam, Netherlands)|November 25, 2010
Influenza vaccine for healthy adult workers: an issue for health authorities or employers?Livio Garattini, Daniela KolevaThe European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 21, 2006
Off-patent drugs in Italy. A short-sighted view?Livio Garattini, Simone GhislandiInternational Journal of Technology Assessment in Health Care|March 25, 2011
Risk sharing agreements: what lessons from Italy?Livio Garattini, Gianluigi CasadeiPageof 10